Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Subject
01 CITALOPRAM HYDROBROMIDE (1)
02 ESCITALOPRAM OXALATE (1)
03 RISPERIDONE (1)
Holder
01 WUXI JIDA PHARMACEUTICAL CO LTD (3)
Country
01 China (3)
Status
01 Active (3)
GDUFA DMF Review
01 Blank (3)